These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7986360)

  • 41. Autoimmune hematologic diseases associated with infraclinical systemic lupus erythematosus in four patients. A human equivalent of the NZB mice.
    Favre H; Chatelanat F; Miescher PA
    Am J Med; 1979 Jan; 66(1):91-95. PubMed ID: 570354
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Erythrocyte deformability changes in autoimmune hemolytic anemia during development of NZB mice and their (NZB/NZW)F1 hybrid.
    Ballas SK; Tabbara KF; Murphy DL; Mohandas N; Clark MR; Shohet SB
    J Clin Lab Immunol; 1985 Apr; 16(4):217-22. PubMed ID: 4020852
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The anti-erythrocyte autoimmune response of NZB mice. Identification of two distinct autoantigens.
    Diiulio NA; Fairchild RL; Caulfield MJ
    Immunology; 1997 Jun; 91(2):246-51. PubMed ID: 9227324
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Genetic studies of anti-erythrocyte autoantibody production].
    Ozaki S; Shirai S
    Rinsho Ketsueki; 1983 Sep; 24(9):1152-60. PubMed ID: 6663723
    [No Abstract]   [Full Text] [Related]  

  • 45. AUTOIMMUNE HEMOLYTIC ANEMIA IN NZB/B1 MICE TREATED WITH THE CORTICOSTEROID DRUG BETAMETHASONE.
    CASEY TP; HOWIE JB
    Blood; 1965 Apr; 25():423-31. PubMed ID: 14284332
    [No Abstract]   [Full Text] [Related]  

  • 46. Multiple loci are linked with anti-red blood cell antibody production in NZB mice -- comparison with other phenotypes implies complex modes of action.
    Lee NJ; Rigby RJ; Gill H; Boyle JJ; Fossati-Jimack L; Morley BJ; Vyse TJ
    Clin Exp Immunol; 2004 Oct; 138(1):39-46. PubMed ID: 15373903
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evidence that autoimmunity in NZB mice is caused by a defect in immune specificity rather than a generalized defect in tolerance of self-antigens.
    Knight J; Knight A; Winchester G
    Cell Immunol; 1980 Dec; 56(2):317-22. PubMed ID: 6970625
    [No Abstract]   [Full Text] [Related]  

  • 48. T-helper 1 dominated responses to erythrocyte Band 3 in NZB mice.
    Shen CR; Mazza G; Perry FE; Beech JT; Thompson SJ; Corato A; Newton S; Barker RN; Elson CJ
    Immunology; 1996 Oct; 89(2):195-9. PubMed ID: 8943714
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells.
    Murakami M; Yoshioka H; Shirai T; Tsubata T; Honjo T
    Int Immunol; 1995 May; 7(5):877-82. PubMed ID: 7547714
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation of aggression with serum IgM level in autoimmune-prone NZB mice.
    Nakamura K; Nishimura H; Hirose S
    Brain Res Dev Brain Res; 2005 Oct; 159(2):145-8. PubMed ID: 16140394
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of the spontaneous autoimmune (anti-erythrocyte) response in NZB mice using a pathogenic monoclonal autoantibody and its anti-idiotype.
    Caulfield MJ; Stanko D; Calkins C
    Immunology; 1989 Feb; 66(2):233-7. PubMed ID: 2925223
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lactoferrin lowers the incidence of positive Coombs' test in New Zealand black mice.
    Zimecki M; Wieczorek Z; Mazurier J; Spik G
    Arch Immunol Ther Exp (Warsz); 1995; 43(3-4):207-9. PubMed ID: 8744697
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Silicone gel enhances the development of autoimmune disease in New Zealand black mice but fails to induce it in BALB/cAnPt mice.
    McDonald AH; Weir K; Schneider M; Gudenkauf L; Sanger JR
    Clin Immunol Immunopathol; 1998 Jun; 87(3):248-55. PubMed ID: 9646834
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autoimmune hemolytic anemia and autoimmune neutropenia in a child with erythroblastopenia of childhood (TEC) caused by human herpesvirus-6 (HHV-6).
    Yagasaki H; Kato M; Shimizu N; Shichino H; Chin M; Mugishima H
    Ann Hematol; 2011 Jul; 90(7):851-2. PubMed ID: 20922523
    [No Abstract]   [Full Text] [Related]  

  • 55. The immunologic basis of autoimmunization.
    Schwartz RS
    J Allergy Clin Immunol; 1977 Jul; 60(1):69-72. PubMed ID: 326848
    [No Abstract]   [Full Text] [Related]  

  • 56. [Immunological function and diseases; a study using New Zealand mice].
    Shiokawa Y; Abe T
    Nihon Rinsho; 1973 Dec; 31(12):3355-61. PubMed ID: 4799678
    [No Abstract]   [Full Text] [Related]  

  • 57. Genes determining autoimmune disease in New Zealand mice.
    Knight JG; Adams DD
    J Clin Lab Immunol; 1981 May; 5(3):165-70. PubMed ID: 7241566
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The nature of the development of autoimmune hemolytic anemia in thymectomized animals exposed to the action of ionizing radiation].
    Sharafan VA
    Fiziol Zh (1994); 1997; 43(5-6):25-30. PubMed ID: 9463004
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The SOD1 transgene expressed in erythroid cells alleviates fatal phenotype in congenic NZB/NZW-F1 mice.
    Otsuki N; Konno T; Kurahashi T; Suzuki S; Lee J; Okada F; Iuchi Y; Homma T; Fujii J
    Free Radic Res; 2016 Jul; 50(7):793-800. PubMed ID: 27080108
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IL-10 and the cytokine network in the pathogenesis of human autoimmune hemolytic anemia.
    Toriani-Terenzi C; Fagiolo E
    Ann N Y Acad Sci; 2005 Jun; 1051():29-44. PubMed ID: 16126942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.